Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency

Praxedis Martin; Dominique Talabot-Ayer; Christian A Seemayer; Solenne Vigne; Céline Lamacchia; Emiliana Rodriguez; Axel Finckh; Dirk E Smith; Cem Gabay; Gaby Palmer

doi:10.1186/ar4143

Download references

Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency

Praxedis Martin, Dominique Talabot-Ayer, Christian A Seemayer, Solenne Vigne, Céline Lamacchia, Emiliana Rodriguez, Axel Finckh, Dirk E Smith, Cem Gabay and Gaby Palmer^*

* Corresponding author: Gaby Palmer Gaby.Palmer@unige.ch

Arthritis Research & Therapy 2013, 15:R13 doi:10.1186/ar4143

Include	Article citation and all cited references Cited references only Article citation only
Format	EndNote, Zotero or Papers Reference Manager Refworks BibTeX

Arthritis Research & Therapy

Viewing options

Associated material

Tools

Share this article

Download references

Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency

Arthritis Research & Therapy

Viewing options

Associated material

Related literature

Other articles by authors

Related articles/pages

Tools

Share this article

Email updates

Download references

Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency